Clinical trial
A Phase II/III Study of JR-141 in Patients With Mucopolysaccharidosis II
NCT03568175 is registered in ClinicalTrials.gov with JCR Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II/III Study of JR-141 in Patients With Mucopolysaccharidosis II
- Lead sponsor
- JCR Pharmaceuticals Co., Ltd.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 1, 2018
- Completion date
- February 20, 2020
- Enrollment
- 28 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.